Lebbé, C.

Inserm · Assistance Publique – Hôpitaux de Paris · Hôpital Saint-Louis · Université Paris Diderot · HIPI - Immunologie humaine, physiopathologie et immunithérapie

1 paper on CoChatORCID 0000-0002-5854-7290

Most cited papers

Verified
Regional differences in overall survival (OS) in patients with advanced melanoma (MEL) who received nivolumab (NIVO) combined with ipilimumab (IPI) or NIVO alone in a phase 3 trial (CheckMate 067)
Grob, J.-J., Schadendorf, D., Wagstaff, J., Márquez-Rodas, I., Lebbé, C., Ascierto, P. A., Hodi, F. S., Grossmann, K., Hassel, J. C., Walker, D., et al. (2017) · Annals of Oncology
Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management
Cited by 8

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free